Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Successfully Completes Gravity Geophysical Survey at Cadiz Dry Lake Project

Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) this morning announced that Hasbrouck Geophysics Inc. has successfully completed a large-scale gravity geophysical survey at the company’s Cadiz Dry Lake Project located in the Mojave area of California. Hasbrouck Geophysics collected gravity readings from 89 new stations, integrated 85 public domain gravity stations, and integrated data over approximately 211 km2. Repeat readings of new stations ranged between 0.014 and 0.027 mGals, while the spread for base readings (both field and absolute) is between 0.009 and 0.015 mGals, representing that the data are of excellent quality. The results obtained from the survey will be used to plan additional exploration, including further geophysical surveys to identify Li-brine bearing zones and structural control. “The results from this high quality geophysical survey are very encouraging. This work has defined a closed basin with infill deposits that are known to host lithium brines, based on preliminary sampling of extraction wells operated by the permitted producer. Standard Lithium’s excellent relationship with the Project’s permitted operator will allow for further exploration of the deeper basin infill deposits under the existing permitted brine operations,” Standard Lithium president and COO Dr. Andy Robinson stated in the news release.

To view the full press release, visit http://ibn.fm/bIHRM

About Standard Lithium

Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills and modern brine processing technologies. The company is currently engaged in the exploration and resource development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also rapidly conducting resource evaluation on up to 33,000 acres of brine leases located in the Smackover Formation in Southern Arkansas. For more information, visit the company’s website at www.StandardLithium.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Standard Lithium Ltd. STLHF | Leave a comment

MissionIRNewsBreaks – Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) and WeedMD, Inc. (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE) Enter Agreement to Merge

Canada’s first vertically-integrated cannabis brand house Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF), along with WeedMD Inc. (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE), this morning announced that the companies have entered into a definitive agreement to merge the two companies. Upon completion of the transaction, existing Hiku and WeedMD shareholders will own roughly 51.75% and 48.25% of the combined company, respectively, on a fully-diluted basis. Common shares of the resulting entity are anticipated to be listed on the TSX Venture Exchange, subject to regulatory approvals. Hiku and WeedMD are hosting a conference call on Friday, April 20, 2018 beginning at 10 a.m. EST. To participate on the call, dial 1-800-806-5484 and enter the passcode 2900959#. “The combination of Hiku and WeedMD creates a cannabis company capable of fulfilling the vision of delivering the best in class experiences from in-store to product, from medical to adult-use, but also capturing full retail and wholesale margins. Our combined offerings create a company that is insulated from potential wholesale margin compression and is ready to scale its offering globally,” Hiku CEO Alan Gertner stated in the news release.

To view the full press release, visit http://ibn.fm/ZmJs8

About WeedMD

WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of medical cannabis and oils under the ACMPR. The company operates a 26,000 sq. ft. indoor facility in Aylmer, Ontario, and is awaiting its second-site cultivation license for its greenhouse facility located in Strathroy, Ontario, representing 610,000 sq. ft. or 14 acres under glass. WeedMD has entered into supply agreements in addition to strategic relationships with established cannabis brands. WeedMD is focused on providing medical cannabis to the seniors’ markets in Canada through its proprietary seniors care program. It is dedicated to educating healthcare practitioners and furthering public understanding of the role that medical cannabis plays – including as it pertains to regulatory requirements, indications and potential side effects. For more information, visit the company’s website at www.WeedMD.com.

About Hiku Brands Company Ltd.

Hiku is focused on building a portfolio of iconic, engaging cannabis brands, unsurpassed retail experiences and handcrafted cannabis production. With a national retail footprint led by Tokyo Smoke, craft cannabis production through DOJA’s ACMPR licensed grow, and Van der Pop’s female-focused educational platforms, Hiku houses an industry-leading portfolio that aims to set the bar for cannabis brands in Canada. Hiku’s wholly-owned subsidiary, DOJA Cannabis Ltd., is a federally licensed to cultivate and sell cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), owning two production facilities in the heart of British Columbia’s Okanagan Valley. Hiku’s wholly-owned subsidiary, Tokyo Smoke has been conditionally awarded one of four master retail licenses in Manitoba. Hiku also operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario. For more information, visit the company’s website at www.Hiku.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Hiku Brands Company Ltd. DJACF, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Sunniva Inc. (SNNVF) Announces Plans to Release FY2017 Results on April 24

Vertically integrated medical cannabis company Sunniva Inc. (OTCQX: SNNVF) yesterday announced plans to release its fiscal results for the fourth quarter and year ended December 31, 2017, after market close on Tuesday, April 24, 2018. Per the update, the company’s executive management team will discuss the results during a conference call on Wednesday, April 25, 2018, at 11:30 am Eastern Time. Those interested in participating in this call can dial 1-800-319-4610 or 604-638-5340. An audio replay of the call will also be made available for two weeks following its conclusion. To access this replay, interested parties should dial 1-855-669-9658 or 604-674-8052 and enter access code 5312.

To view the full press release, visit http://ibn.fm/1yNXv

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current good manufacturing practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at www.Sunniva.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Sunniva Inc. SNNVF | Leave a comment

Earth Science Tech, Inc. (ETST) Has Team in Place to Become Licensed Distributor of Controlled Substances in Canada

  • Jad Nammour joins the company as new Chief of Pharmacy, bringing over 20 years of experience to ETST
  • Positioned for sales growth with a strong, completed team of industry professionals
  • Accelerating the development and commercialization of new products in Canada and overseas

Earth Science Tech, Inc. (OTC: ETST), a Florida-based biotech company focused on cannabis and cannabinoid research and development, nutraceuticals and pharmaceuticals, as well as on R&D for certain medical devices, recently announced Jad Nammour as its new Chief of Pharmacy (http://ibn.fm/dnv0x). Nammour is trained to develop master formulae, the templates for mass production of non-sterile medicinal products. Having a certified pharmacist on staff is required by law to obtain a license to distribute controlled substances. Nammour fills this final important technical gap in the production and development teams. His job will be to make sure that controlled substances and drugs are managed, handled and stored correctly. He will also help in the development and marketing of the company’s nutraceutical patents, pharmacological products and medical devices. The adding of the new Chief of Pharmacy brings ETST one step closer to obtaining a final license to distribute controlled substances, and completes the management and development teams.

ETST has positioned itself for growth in 2018 through the addition of its new COO, Gagan Hunter, in March (http://ibn.fm/yDzGg) and the final addition of new Chief of Pharmacy Jad Nammour in April. In a news release, Dr. Michel Aube, CEO & CSO, stated “We have all of the knowledge, experience and proficiency that we need to bring our products to the marketplace and become a licensed distributor of drugs and controlled substances in Canada, as announced earlier this year.” The company holds three wholly owned subsidiaries: Earth Science Pharmaceutical, Cannabis Therapeutics, and KannaBidioiD. In addition, Canadian subsidiary Canna Inno Laboratories Inc. was formed by ETST in 2017, as a strategic Montreal, Canada-based company, to give ETST a foothold in Québec, providing the company with access to government grants.

The company has already received a grant through Canna Inno Laboratories Inc. from the Government of Québec to support the pre-launch process of three CBD-based products that aim to prevent common causes of cancer and help reduce occurrence rates. ETST is strategically working to improve treatments for different diseases on a global scale. Human clinical trials are set to begin in 2019, or later, in producing an over-the-counter (OTC) drug and a cannabinoid companion generic drug that battles opioid dependency. ETST is planning to investigate the synergies between mineral elements and cannabinoid industrial hemp oil. This could potentially be used as a treatment for opioid dependency. In March 2018, ETST announced its membership in the largest innovative business acceleration program in Québec (http://ibn.fm/94Dtr). With this membership, the company is poised to accelerate the development and commercialization of new products in Canada and overseas.

For more information, visit the company’s website at www.EarthScienceTech.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Earth Science Tech, Inc. ETST | Leave a comment

Net Element, Inc. (NASDAQ: NETE) Increases Revenues, Records Double Digit Growth in Mobile Transaction Markets

  • Transactions processed rose by 14 percent to reach $2.8 billion in 2017
  • Net Element launches new service, Fast Pass Funding, on proprietary Netevia platform
  • Global ecommerce market reached $2.7 trillion in 2017, expected to hit $4.5 trillion in 2021
  • Surge in mobile payments market tied to convenience, security
  • JGR Capital initiates coverage on Net Element, Inc.

Global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) continues to embrace emerging and disruptive technologies in its quest to improve the experience of mobile payment solutions for its clients and their customers. Net Element launched a wide array of partnerships in 2017, all geared toward connecting and simplifying payments across multiple sales channels throughout the globe.

SeeThruEquity noted in its recent update (http://ibn.fm/fdlml) to Net Element’s 2017 performance report that the company’s revenue growth was driven by its North America Transactions Solutions business segment, which topped 21 percent year-over-year. Full year revenues for 2017 of $60.1 million represented an increase of about 11 percent over 2016’s $54.3 million. The company also improved its balance sheet, ending the year with cash on hand of $11.3 million and total financial debt of $7 million.

In addition, JGR Capital just announced initiation of coverage on Net Element (http://ibn.fm/APb09), highlighting the following:

  • NETE has grown its North American Transactions Segment 28 percent year-over-year, largely attributable to its successes with the Unified Payments brand.
  • Net Element recently launched Netevia, its new product that is part of its decentralized blockchain technology solutions initiative.
  • Net Element recently joined the Enterprise Ethereum Alliance, which is the world’s largest open-source blockchain initiative.
  • NETE completed a $7.55 million restricted common stock and warrant private placement with an institutional investor to buttress growth with its blockchain initiatives.

One of the highlights of the report includes the recent news of Net Element’s same-day funding service called Fast Pass Funding. Launched by subsidiary Unified Payments, Fast Pass Funding works through the company’s proprietary multichannel payments platform, Netevia. This visionary platform, which connects and simplifies payments across a number of channels through a single integration point – including point-of-sale, ecommerce and mobile devices – gives eligible merchants access to funds in as little as three hours during regular business days (http://ibn.fm/h0v9o). That’s a huge improvement over the average funding times of between 12 and 24 hours. Fast Pass Funding is also delivered to merchants using Aptito, Net Element’s proprietary cloud-based restaurant point-of-sale and management system.

As a member of the Ethereum Alliance, the world’s largest open-source blockchain initiative with over 250-member companies, Net Element also plans to integrate new blockchain technologies into its Fast Pass Funding platform.

“We are very pleased with our 2017 progress and the strong balance sheet position as of December 31, 2017, which we believe positions the company for future growth and opportunities,” Oleg Firer, CEO of Net Element, said in a news release describing the company’s year in review and plans for 2018 (http://ibn.fm/sTrbi).

Global data from Statista (http://ibn.fm/ngnIC) anticipates a massive increase in worldwide ecommerce sales, from $2.7 trillion in 2017 to $4.5 trillion in 2021 – bringing with it opportunities too big to ignore. Net Element continues to keep an eye on the prize, pursuing strategies in the rapidly changing payment solutions market that are designed to achieve superior results, Firer said.

For more information, visit the company’s website at www.NetElement.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Net Element Inc. NETE | Leave a comment

MissionIRNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Featured in Research Report by JGR Capital

Independent equity research firm JGR Capital this morning announced that it has initiated coverage on Net Element, Inc. (NASDAQ: NETE), a global financial technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment spanning across point-of-sale, e-commerce and mobile devices. Key highlights from the report include the 28 percent year-over-year growth of Net Element’s North American Transactions Segment, which is largely attributable to its successes with the Unified Payments brand; the company’s recent launch of Netevia, a proprietary multi-channel payments platform; its membership in the Enterprise Ethereum Alliance, noted as the world’s largest open-source blockchain initiative; and its completion of a $7.55 million restricted common stock and warrant private placement with an institutional investor aimed at funding its ongoing blockchain initiatives.

To view the full report, visit http://ibn.fm/mrVPQ

To view the full press release, visit http://ibn.fm/llQhw

About Net Element

Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., it aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500™. In 2017, Net Element was recognized by South Florida Business Journal’s as one of 2016’s fastest growing technology companies. Further information is available at www.NetElement.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Net Element Inc. NETE | Leave a comment

MissionIRNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRA: 6F6) (WKN: A2AKL8) Acquires Stake in LocoNoco, Inc.

Blockchain-focused venture builder Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) this morning announced that it has entered into an agreement to acquire 9.09% of all issued and outstanding shares of LocoNoco, Inc. for $500,000, subject to all requisite regulatory approvals. LocoNoco Inc. is a cloud-native decision-making platform that delivers simplicity, reusability and transportability in an era of smart, automated processes. Per the definitive share purchase agreement, Victory Square will satisfy the purchase price through cash installments totaling $500,000. “This investment, along with others we have made thus far in 2018, are aligned with our thesis at Victory Square that emerging technologies such as AI and Blockchain will bring major changes to traditional business models,” Victory Square CEO Shafin Diamond Tejani stated in the news release.

To view the full press release, visit http://ibn.fm/CRtlw

About Victory Square Technologies Inc.

Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.VictorySquare.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Victory Square Technologies Inc. VSQTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Terminates LOI for the Acquisition of Agro-Biotech

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning reported that it has terminated the previously announced letter of intent (“LOI”) that it had entered into for the acquisition of Agro-Biotech. The company is currently reviewing its available legal alternatives to recover the amounts expended by the company in the pursuit of the transaction, as well as additional damages resulting from the non-completion of the transaction. “Despite our extensive efforts, we have been unable to complete the acquisition of Agro-Biotech in accordance with the terms and conditions initially agreed upon by the parties. While we are extremely disappointed with this outcome, Pivot continues to pursue other value-enhancing opportunities for the Company and its shareholders,” Pivot CEO Patrick Frankham stated in the news release.

To view the full press release, visit http://ibn.fm/uEWox

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green StreamHealth Solutions Inc. (“PGS”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. PGS has acquired worldwide rights to “RTIC” Ready-To-Infuse Cannabis powder to oil technology, BiPhasix™ Transdermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol, and tetrahydrocannabinol-based products. PGS’ initial product development candidates will include topical treatments for women’s sexual dysfunction (PGS-N005), as well as psoriasis (PGS-N007), and an oral product (PGS-N001) for cancer supportive care. For more information, visit the company’s website at www.PivotPharma.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

 

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Entering Multi-billion-dollar Industries through Strategic Acquisitions

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is developing disruptive formulations for cannabis-infused markets. An article discussing the company reads: “Pivot’s acquisition of California’s ERS Holdings, LLC in February not only strengthened its options for enhanced health and wellness products; the move gave the company added visibility to beverage makers such as beer companies working to mitigate a potential decline in profits as their customers divert discretionary income from alcohol consumption to cannabis consumption. … “The (Ready-To-Infuse-Cannabis technology) family of patents will be transformational for the food and beverage industry. Based on our interaction with key players in the beverage market, we anticipate that there will be a significant substitution in consumer choices towards cannabis infused drinks. With this acquisition, we have positioned Pivot to be at the forefront of this enormous new market,” Pivot CEO Patrick Frankham stated in a news release about the acquisition (http://ibn.fm/Mi8rs).”

To view the full article, visit http://ibn.fm/461PR

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green StreamHealth Solutions Inc. (“PGS”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. PGS has acquired worldwide rights to “RTIC” Ready-To-Infuse Cannabis powder to oil technology, BiPhasix™ Transdermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol, and tetrahydrocannabinol-based products. PGS’ initial product development candidates will include topical treatments for women’s sexual dysfunction (PGS-N005), as well as psoriasis (PGS-N007), and an oral product (PGS-N001) for cancer supportive care. For more information, visit the company’s website at www.PivotPharma.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Sees 2018 as Year of Growth for BaroFold, Ultra Shear Technology Programs

Pressure BioSciences (OTCQB: PBIO) recently announced newly-issued patents in Ultra Shear Technology (“UST”) that address broad markets for stable, water-soluble nanoemulsions, including cannabinoids. An article further discussing the company reads: “With the BaroFold acquisition and the new developments in Ultra Shear Technology (including two issued patents), Pressure BioSciences now has three distinct working groups — its research products and services unit, its biologics contract research services unit and its Ultra Shear Technology (UST) development unit. … The UST platform incorporates a novel technique based on the use of intense shear forces generated from ultra-high pressure valve discharge, which the company believes can drive a number of commercially important areas including the preparation of extended shelf-life ‘clean label’ food and the formulation of high-quality, stable nanoemulsions that are mixtures of two or more liquids that normally would not mix with each other without the addition of chemicals called emulsifiers.”

To view the full article, visit http://ibn.fm/LgNlr

About Pressure BioSciences Inc.

Pressure BioSciences Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of PBI’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment